Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
Oncogene
|
November 11, 1999
Isolation and initial characterization of the BRCA2 promoter
P L Davis, A Miron, L M Andersen, et al.
Journal of Surgical Oncology
|
December 1, 1991
p53 alterations in all stages of breast cancer
A M Davidoff, B J Kerns, J C Pence, et al.
American Journal of Obstetrics and Gynecology
|
January 1, 1994
The p53 tumor suppressor gene frequently is altered in gynecologic cancers
A Berchuck, M F Kohler, J R Marks, et al.
Oncogene
|
January 1, 1992
Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines
A M Davidoff, J C Pence, N A Shorter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 1995
Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients
D H Harpole, J R Marks, W G Richards, et al.
Cancer Research
|
January 1, 1995
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression
D H Harpole, J E Herndon, W G Wolfe, et al.
Journal of Surgical Oncology
|
September 1, 1991
Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining
J C Pence, A M Kizilbash, B J Kerns, et al.
Obstetrics and Gynecology
|
January 1, 1994
Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas
F S Liu, M F Kohler, J R Marks, et al.
Journal of Neuroscience Research
|
September 1, 1989
Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas
H J Cho, M Seiberg, I Georgoff, et al.
Cellular Immunology
|
January 8, 1999
Repression of interleukin-2 mRNA translation in primary human breast carcinoma tumor-infiltrating lymphocytes
C B Lopez, T D Rao, H Feiner, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
Oncogene
|
November 11, 1999
Isolation and initial characterization of the BRCA2 promoter
P L Davis, A Miron, L M Andersen, et al.
Journal of Surgical Oncology
|
December 1, 1991
p53 alterations in all stages of breast cancer
A M Davidoff, B J Kerns, J C Pence, et al.
American Journal of Obstetrics and Gynecology
|
January 1, 1994
The p53 tumor suppressor gene frequently is altered in gynecologic cancers
A Berchuck, M F Kohler, J R Marks, et al.
Oncogene
|
January 1, 1992
Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines
A M Davidoff, J C Pence, N A Shorter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 1995
Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients
D H Harpole, J R Marks, W G Richards, et al.
Cancer Research
|
January 1, 1995
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression
D H Harpole, J E Herndon, W G Wolfe, et al.
Journal of Surgical Oncology
|
September 1, 1991
Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining
J C Pence, A M Kizilbash, B J Kerns, et al.
Obstetrics and Gynecology
|
January 1, 1994
Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas
F S Liu, M F Kohler, J R Marks, et al.
Journal of Neuroscience Research
|
September 1, 1989
Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas
H J Cho, M Seiberg, I Georgoff, et al.
Cellular Immunology
|
January 8, 1999
Repression of interleukin-2 mRNA translation in primary human breast carcinoma tumor-infiltrating lymphocytes
C B Lopez, T D Rao, H Feiner, et al.
Page
of 8